InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by WORBOYS PHILIP D, Vice-Président Senior, Recherche et Science Translational. Director active across 1 companies, notably Theravance Biopharma, Inc.. In total, 6 reports have been recorded. The latest transaction was disclosed on 19 November 2021 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
€31,6944,310 shares@ €7.35370.0038% mcap21.7% of flow
Ordinary Shares
SEC:0001415889-21-005465·
€31,6944,310 shares@ €7.35370.0038% mcap10.8% of flow
Ordinary Shares
SEC:0001415889-21-005465:0·
€51,8244,307 shares@ €12.03260.0062% mcap35.4% of flow
Ordinary Shares
SEC:0001179110-21-008406·
€51,8244,307 shares@ €12.03260.0062% mcap17.7% of flow
Ordinary Shares
SEC:0001179110-21-008406:0·
€62,7534,310 shares@ €14.55990.0075% mcap42.9% of flow
Ordinary Shares
SEC:0001179110-21-005854·
€62,7534,310 shares@ €14.55990.0075% mcap21.5% of flow
Ordinary Shares
SEC:0001179110-21-005854:0·
6 of 6 declarations
About WORBOYS PHILIP D
Philip D. Worboys is the Senior Vice President of Research & Translational Science at Theravance Biopharma, Inc. He is responsible for leading the company's research and development initiatives. Philip plays a key role in scientific innovation and the implementation of new therapies. His expertise in the pharmaceutical field contributes to Theravance's mission of improving patients' lives.
